| In: Taylor and Hoyt's Pediatric Ophthalmology and Strabismus | A systematic review and meta-analysis on the safety of vascular endothelial growth factor VEGF inhibitors for the treatment of retinopathy of prematurity |
|---|---|
| Anti-vascular endothelial growth factor VEGF drugs for treatment of retinopathy of prematurity review | What is retinopathy of prematurity |
: Valeant Pharmaceuticals North America LLC; 2016.
9| Short-term outcomes after very low-dose intravitreous bevacizumab for retinopathy of prematurity | |
|---|---|
| Retinopathy of prematurity: Treatment and prognosis |
.
6.
14